U.S. Department of Health and Human Services
This section summarizes key updates to the NIH COVID-19 Treatment Guidelines. These updates include information about the BA.1 and BA.1.1 subvariants of the Omicron (B.1.1.529), recommendations against the use of ivermectin for the treatment of COVID-19, except in clinical trials, updated information on the role of bebtelovimab in the treatment of nonhospitalized patients with mild to moderate COVID-19 who are at high risk of disease progression, and updated information on changes to the use of COVID-19 convalescent plasma.
The Guidelines also include updates about the therapeutic management of nonhospitalized adults with COVID-19, the use of antibody-based products, and recommendations related to the the Omicron BA.2 subvariant.
- Click on the PDF link below to access this section.
- Return to this page. Click “Next” below access the next section.
- The last section provides a link to the quiz, registration, payment, and certificate.